Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2022 / Power List / Justin Godinho

Justin Godinho

Investigator, Drug Substance and Product Analysis, GlaxoSmithKline

  • Profile

Meet Justin Godinho

Challenges? As a chromatographer, I believe the biggest analytical challenge is the increasing complexity of biopharmaceuticals. Characterization of large therapeutic proteins including monoclonal antibodies, antibody drug conjugates, bispecific antibodies, and coformulations offers a rich and challenging set of analytical chromatography hurdles.

Predictions? I believe there will be increased demand for simultaneous characterization of large proteins and their supporting sample constituents. Currently, a series of separation techniques is required for complete analytical characterization. We have seen some research directions shift towards innovative methods to elucidate multiple critical quality attributes simultaneously. I also expect greater adoption and drive towards multidimensional separation technologies and MS based instrumentation in QC settings to safely deliver well-characterized molecules to patients with fewer more comprehensive analytical tests.

Advice? Find opportunities to collaborate. More specifically, seek out colleagues that have different skill sets. Your work will benefit if you are challenged to think differently.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.